A. Lipton
- Oncology top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Molecular Biology
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Barbara WeberDaniel F. HayesDebu TripathyMark D. PegramSharon A. BaughmanD L BalyJohn A. GlaspyJosé Baselga
- Topics
- Bone health and treatments (13 papers)Radiopharmaceutical Chemistry and Applications (8 papers)HER2/EGFR in Cancer Research (5 papers)
- Partner nations
- United StatesIndiaBelgium
In The Last Decade
A. Lipton
28 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 1.5k
- Radiology, Nuclear Medicine and Imaging 818
- Molecular Biology 524
- Cancer Research 307
- Pulmonary and Respiratory Medicine 286
Countries citing papers authored by A. Lipton
This map shows the geographic impact of A. Lipton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lipton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lipton more than expected).
Fields of papers citing papers by A. Lipton
This network shows the impact of papers produced by A. Lipton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lipton. The network helps show where A. Lipton may publish in the future.
Co-authorship network of co-authors of A. Lipton
This figure shows the co-authorship network connecting the top 25 collaborators of A. Lipton. A scholar is included among the top collaborators of A. Lipton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lipton. A. Lipton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 3 | |
| 3 | 161 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 7 | |
| 7 | 4 | |
| 8 | 2 | |
| 9 | 5 | |
| 10 | 102 | |
| 11 | 11 | |
| 12 | 14 | |
| 13 | Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.breakdown → | 848 |
| 14 | 457 | |
| 15 | 1 | |
| 16 | 247 | |
| 17 | 37 | |
| 18 | The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis. | 57 |
| 19 | 44 | |
| 20 | Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination. | 71 |
About A. Lipton
A. Lipton is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Geriatrics and Gerontology, having authored 28 papers that have together received 2.1k indexed citations. Recurring topics across this work include Bone health and treatments (13 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Oncology (1.5k citations), Radiology, Nuclear Medicine and Imaging (818 citations) and Geriatrics and Gerontology (91 citations). A. Lipton has collaborated with scholars based in United States, India and Belgium. Frequent co-authors include Barbara Weber, Daniel F. Hayes, Debu Tripathy, Mark D. Pegram, Sharon A. Baughman, D L Baly, John A. Glaspy, José Baselga, Dennis J. Slamon and Kim Leitzel. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.